Literature DB >> 10047972

Molecular genetics and epidemiology of prostate carcinoma.

E Ruijter1, C van de Kaa, G Miller, D Ruiter, F Debruyne, J Schalken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10047972     DOI： 10.1210/edrv.20.1.0356

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  34 in total

1.  Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells.

Authors:  S Yeh; H Y Kang; H Miyamoto; K Nishimura; H C Chang; H J Ting; M Rahman; H K Lin; N Fujimoto; Y C Hu; A Mizokami; K E Huang; C Chang
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

2.  Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

Authors:  Silvana G P Campos; Bianca F Gonçalves; Wellerson R Scarano; Lara S Corradi; Fernanda C A Santos; Ana M G Custodio; Patricia S L Vilamaior; Rejane M Góes; Sebastião R Taboga
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

Review 3.  Differential action of glycoprotein hormones: significance in cancer progression.

Authors:  Vijayakumar Govindaraj; Swathy V Arya; A J Rao
Journal:  Horm Cancer       Date:  2013-10-16       Impact factor: 3.869

4.  Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Authors:  Uddhav P Kelavkar; Wayne Glasgow; Sandra J Olson; Barbara A Foster; Scott B Shappell
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

5.  Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.

Authors:  Nathan G Dolloff; Shannon S Shulby; Autumn V Nelson; Mark E Stearns; Gregg J Johannes; Jeff D Thomas; Olimpia Meucci; Alessandro Fatatis
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

Review 6.  Interrogating genomic and epigenomic data to understand prostate cancer.

Authors:  Jung Kim; Jindan Yu
Journal:  Biochim Biophys Acta       Date:  2012-01-03

7.  Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.

Authors:  Yu Wang; Deepa Radhakrishnan; Xin He; Donna M Peehl; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

8.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

9.  A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.

Authors:  M A Trujillo; M J Oneal; S McDonough; R Qin; J C Morris
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

Review 10.  Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.

Authors:  Hui Zhu; Jorge A Garcia
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.